Tafadzwa Chaunzwa, MD, a researcher within the Synthetic Intelligence in Medication (AIM) Program at Mass Normal Brigham and a senior resident doctor on the Harvard Radiation Oncology Program, is the lead writer of a paper revealed in JAMA Oncology. Chaunzwa and senior writer Hugo Aerts, PhD, director of the AIM Program, and affiliate professor at Harvard College, shared highlights from their paper.
How would you summarize your examine for a lay viewers?
As therapies like immunotherapy enhance most cancers survival charges, there’s a rising want for medical decision-support instruments that predict remedy response and affected person outcomes. That is significantly vital for lung most cancers, which stays the highest reason for most cancers dying globally. Earlier research linked physique mass index (BMI) with lung most cancers outcomes and immunotherapy drug unintended effects. Nevertheless, BMI is a restricted measure that does not seize particulars about totally different physique tissues and their interplay with most cancers therapies. We used medical imaging and synthetic intelligence (AI) to research physique composition in a big cohort of sufferers with lung most cancers that has unfold to different components of the physique. Our examine discovered that adjustments in muscle mass and fats high quality throughout remedy are vital indicators of outcomes for this inhabitants.
What data gaps does your examine assist to fill?
As we proceed to enhance the remedy of superior lung most cancers with totally different systemic brokers, together with immunotherapy medication, biomarkers which are each prognostic and predictive of remedy response are more and more wanted to tell medical selections. Prior research recognized an affiliation between BMI and lung most cancers outcomes. An affiliation between BMI and the incidence of unintended effects with immunotherapy has additionally been elucidated. Nevertheless, BMI alone is a crude metric that doesn’t seize the distribution and relative contributions of various physique tissues. Medical imaging-based analyses of physique composition are being more and more explored; nevertheless, within the setting of superior non-small cell lung most cancers (NSCLC), research have been restricted by small pattern sizes and guide and difficult-to-reproduce methodologies.
How did you conduct your examine?
We got down to carry out complete physique composition evaluation in giant cohorts of people handled for superior or metastatic lung most cancers with totally different systemic medication. We developed a strong end-to-end AI-based platform to help with this process.
What did you discover?
We discovered that whereas the distribution of various tissue compartments in the beginning of cancer-directed remedy had some worth, the change in these measurements over the course of remedy was extra strongly related to affected person outcomes. Particularly, we discovered that loss in muscle mass was a poor prognostic consider sufferers handled with chemotherapy, immunotherapy, or chemoimmunotherapy. Curiously, amongst sufferers receiving immunotherapy, both alone or together with chemotherapy, adjustments within the high quality of the fats underneath the pores and skin (subcutaneous adipose tissue), as seen on CT scans, have been additionally related to the chance for lung most cancers development or mortality.
What are the implications?
This examine presents key breakthroughs that may assist advance the prognostication and surveillance of sufferers receiving immunotherapy for NSCLC. The primary breakthrough is the implementation of an automatic AI-based pipeline for complete physique composition evaluation at scale in a various inhabitants of sufferers receiving immunotherapy and cytotoxic chemotherapy for superior NSCLC. That is the biggest and most in depth such examine, incorporating each real-world knowledge and potential medical trial cohorts, with longitudinal assortment of multimodal knowledge and prolonged follow-up to observe illness response to remedy. Our outcomes reveal the potential of this evaluation framework to offer a extra nuanced understanding of the connection between physique composition and response to immunotherapy in NSCLC in comparison with crude BMI measurements. This may occasionally have vital medical implications for affected person choice, remedy, and monitoring. The second contribution is sharing this strong end-to-end deep-learning pipeline for automated slice choice and physique compartment segmentation on cross-sectional imaging.
What are the following steps?
We provide the software program as an open-source AI device that seamlessly integrates with platforms for picture evaluation and in addition disseminate it on the modelhub.ai platform. By making this algorithm publicly obtainable, we hope to speed up future research on this area and additional facilitate the event of novel approaches for analyzing advanced most cancers imaging knowledge units. This may enable additional investigation of vital associations established utilizing BMI or guide CT-based physique composition measurements. Extra broadly, advances on this analysis space will assist information the administration of various cancers and enhance our capability for precision oncology.
Supply:
Journal reference:
Chaunzwa, T. L., et al. (2024). Physique Composition in Superior Non-Small Cell Lung Most cancers Handled With Immunotherapy. JAMA Oncology. doi.org/10.1001/jamaoncol.2024.1120.